13 results · 18ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

3DOSE 1ml Syringe

FDA 510(k)
FDA Class 2 ·General Hospital

Sonic

FDA UDI
Sbo Hearing A/S·05714464091577·SONIC ENCHANT SE 10 MNR DG DEMO

OXYCODONE ENZYME IMMUNOASSAY AND OXYCODONE CALIBRATORS AND CONTROLS

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

Vital-Port Vascular Access System Power Injectable Port

FDA 510(k)
FDA Class 2 ·General Hospital

PINNACLE DM LINER 54_47

FDA Adverse Event
Injury ·DEPUY IRELAND - 9616671·Product code LPH·October 10, 2025

VITAL-PORT ATTACHED SILICONE CATHETER WITH INT TITANIUM POWER INJECTABLE PORT

FDA Adverse Event
Injury ·COOK VASCULAR INC·Product code LJT·January 7, 2016

LCS 3PEG MOD ROT PAT CEM STD

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS, INC.·Product code NJL·December 2, 2008

SYNCHROMED II

FDA Adverse Event
Injury ·MEDTRONIC NEUROMODULATION·Product code LKK·September 12, 2011

SPECTRUM INFUSION PUMP

FDA Adverse Event
Injury ·BAXTER HEALTHCARE CORPORATION·Product code FRN·July 19, 2013

VITAL-PORT ATTACHED SILICONE CATHETER WITH INT TITANIUM POWER INJECTABLE PORT

FDA Adverse Event
Malfunction ·COOK VASCULAR INC·Product code LJT·January 3, 2019

VITAL-PORT ATTACHED SILICONE CATHETER WITH INT TITANIUM POWER INJECTABLE PORT

FDA Adverse Event
Malfunction ·COOK VASCULAR INC·Product code LJT·January 3, 2019

VITAL-PORT

FDA Adverse Event
Injury ·COOK VASCULAR INC·Product code LJT·May 24, 2016

Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.

FDA Enforcement
Class II ·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012